Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population

Journal of Neural Transmission

Volumn 116, Issue 5, 2009, Pages 567-573

  Shahabi, H Niazi ^a   Westberg, L ^a   Melke, J ^a   Hakansson A ^a   Belin, A Carmine ^b   Sydow, O ^b   Olson, L ^b   Holmberg, B ^a   Nissbrandt, H ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytochrome P450 2E1; Haplotype; Parkinson's disease; Polymorphism; SNP; Taq Man

Indexed keywords

CYTOCHROME P450 2E1;

AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; INTRON; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RELATIVE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

AGE OF ONSET; AGED; CHROMOSOME MAPPING; COHORT STUDIES; CYTOCHROME P-450 CYP2E1; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

EID: 67349285751     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0221-1     Document Type: Article

References (51)

1. JK Andersen 2000 What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease? Mech Ageing Dev 118 1-2 15 22
2. O Bandmann J Vaughan P Holmans CD Marsden NW Wood 1997 Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease Lancet 350 9085 1136 1139 (Pubitemid 27454006)
3. J Brockmoller I Cascorbi R Kerb I Roots 1996 Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk Cancer Res 56 17 3915 3925 (Pubitemid 26284739)
4. MR Brzezinski H Boutelet-Bochan RE Person AG Fantel MR Juchau 1999 Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain J Pharmacol Exp Ther 289 3 1648 1653 (Pubitemid 29246702)
5. V Carriere F Berthou S Baird C Belloc P Beaune I de Waziers 1996 Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype Pharmacogenetics 6 3 203 211 (Pubitemid 26226312)
6. SE Daniel AJ Lees 1993 Parkinson's Disease Society Brain Bank, London: overview and research J Neural Transm Suppl 39 165 172 (Pubitemid 23216938)
7. IM Danko NA Chaschin 2005 Association of CYP2E1 gene polymorphism with predisposition to cancer development Exp Oncol 27 4 248 256 (Pubitemid 43139353)
8. MC de Rijk C Tzourio MM Breteler JF Dartigues L Amaducci S Lopez-Pousa JM Manubens-Bertran A Alperovitch WA Rocca 1997 Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease J Neurol Neurosurg Psychiatry 62 1 10 15
9. MC de Rijk LJ Launer K Berger MM Breteler JF Dartigues M Baldereschi L Fratiglioni A Lobo J Martinez-Lage C Trenkwalder A Hofman 2000 Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group Neurology 54 11 Suppl 5 S21 S23
10. S Fahn 2003 Description of Parkinson's disease as a clinical syndrome Ann N Y Acad Sci 991 1 14 (Pubitemid 36793796)
11. S Fahn G Cohen 1992 The oxidant stress hypothesis in Parkinson's disease: evidence supporting it Ann Neurol 32 6 804 812
12. KS Fairbrother J Grove I de Waziers DT Steimel CP Day CL Crespi AK Daly 1998 Detection and characterization of novel polymorphisms in the CYP2E1 gene Pharmacogenetics 8 6 543 552 (Pubitemid 29043387)
13. FM Farin CJ Omiecinski 1993 Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue J Toxicol Environ Health 40 2-3 317 335 (Pubitemid 23344357)
14. FJ Gonzalez 1988 The molecular biology of cytochrome P450s Pharmacol Rev 40 4 243 288 (Pubitemid 19086991)
15. T Hansson N Tindberg M Ingelman-Sundberg C Kohler 1990 Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system Neuroscience 34 2 451 463 (Pubitemid 20110150)
16. Y Hu M Oscarson I Johansson QY Yue ML Dahl M Tabone S Arinco E Albano M Ingelman-Sundberg 1997 Genetic polymorphism of human CYP2E1: characterization of two variant alleles Mol Pharmacol 51 3 370 376 (Pubitemid 27118471)
17. S Itoga F Nomura Y Makino T Tomonaga H Shimada T Ochiai T Iizasa M Baba T Fujisawa S Harada 2002 Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer Alcohol Clin Exp Res 26 8 Suppl 15S 19S
18. P Jenner 2003 Oxidative stress in Parkinson's disease Ann Neurol 53 Suppl 3 S26 S36 (discussion S36-S28)
19. M Joshi RF Tyndale 2006 Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine Neuropharmacology 50 5 568 575
20. II Karuzina AI Archakov 1994 The oxidative inactivation of cytochrome P450 in monooxygenase reactions Free Radic Biol Med 16 1 73 97
21. M Krajinovic H Sinnett C Richer D Labuda D Sinnett 2002 Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia Int J Cancer 97 2 230 236 (Pubitemid 34019960)
22. JM Ladero JA Agundez A Rodriguez-Lescure M Diaz-Rubio J Benitez 1996 RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma Gut 39 2 330 333 (Pubitemid 26276015)
23. HH Liou MC Tsai CJ Chen JS Jeng YC Chang SY Chen RC Chen 1997 Environmental risk factors and Parkinson's disease: a case-control study in Taiwan Neurology 48 6 1583 1588
24. D Lucas R Ferrara E Gonzalez P Bodenez A Albores M Manno F Berthou 1999 Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans Pharmacogenetics 9 3 377 388 (Pubitemid 29376382)
25. OW McBride M Umeno HV Gelboin FJ Gonzalez 1987 A Taq I polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E) Nucleic Acids Res 15 23 10071
26. C Montoliu M Sancho-Tello I Azorin M Burgal S Valles J Renau-Piqueras C Guerri 1995 Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes J Neurochem 65 6 2561 2570
27. H Nissbrandt F Bergquist J Jonason G Engberg 2001 Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse 40 4 294 301 (Pubitemid 32396413)
28. G Pezzoli A Antonini S Barbieri M Canesi L Perbellini A Zecchinelli CB Mariani A Bonetti KL Leenders 1995 n-Hexane-induced parkinsonism: pathogenetic hypotheses Mov Disord 10 3 279 282
29. M Pirmohamed NR Kitteringham LJ Quest RL Allott VJ Green IT Gilmore BK Park 1995 Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians Pharmacogenetics 5 6 351 357 (Pubitemid 26010114)
30. AG Riedl PM Watts RJ Edwards AR Boobis P Jenner CD Marsden 1996 Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera Brain Res 743 1-2 324 328 (Pubitemid 27028788)
31. AG Riedl PM Watts P Jenner CD Marsden 1998 P450 enzymes and Parkinson's disease: the story so far Mov Disord 13 2 212 220 (Pubitemid 28127794)
32. AG Riedl PM Watts CT Brown P Jenner 1999 P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease Adv Neurol 80 271 286
33. HN Shahabi DR Andersson H Nissbrandt 2008 Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production Synapse 62 5 379 388
34. J Sian M Gerlach MB Youdim P Riederer 1999 Parkinson's disease: a major hypokinetic basal ganglia disorder J Neural Transm 106 5-6 443 476 (Pubitemid 29273885)
35. T Sohda M Shimizu S Kamimura M Okumura 1993 Immunohistochemical demonstration of ethanol-inducible P450 2E1 in rat brain Alcohol Alcohol Suppl 1B 69 75 (Pubitemid 24082969)
36. JF Solus BJ Arietta JR Harris DP Sexton JQ Steward C McMunn P Ihrie JM Mehall TL Edwards EP Dawson 2004 Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population Pharmacogenomics 5 7 895 931 (Pubitemid 39386756)
37. H Staudt F Lichtenberger V Ullrich 1974 The role of NADH in uncoupled microsomal monoxygenations Eur J Biochem 46 1 99 106
38. The International HapMap Project (2003) Nature 426(6968):789-796
39. N Tindberg HA Baldwin AJ Cross M Ingelman-Sundberg 1996 Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury Mol Pharmacol 50 5 1065 1072 (Pubitemid 26384843)
40. M Umeno OW McBride CS Yang HV Gelboin FJ Gonzalez 1988 Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression Biochemistry 27 25 9006 9013 (Pubitemid 19021282)
41. SC Upadhya PS Tirumalai MR Boyd T Mori V Ravindranath 2000 Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization Arch Biochem Biophys 373 1 23 34 (Pubitemid 30046486)
42. F Vaglini C Pardini C Viaggi C Bartoli D Dinucci GU Corsini 2004 Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson's disease J Neurochem 91 2 285 298 (Pubitemid 39363428)
43. C Viaggi C Pardini F Vaglini GU Corsini 2006 Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity J Neural Transm Suppl 70 173 176 (Pubitemid 44622196)
44. J Wang Z Liu P Chan 2000 Lack of association between cytochrome P450 2E1 gene polymorphisms and Parkinson's disease in a Chinese population Mov Disord 15 6 1267 1269
45. TT Warner AH Schapira 2003 Genetic and environmental factors in the cause of Parkinson's disease Ann Neurol 53 Suppl 3 S16 S23 (discussion S23-S15)
46. PM Watts AG Riedl DC Douek RJ Edwards AR Boobis P Jenner CD Marsden 1998 Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase Neuroscience 86 2 511 519 (Pubitemid 28293929)
47. H Wilms L Zecca P Rosenstiel J Sievers G Deuschl R Lucius 2007 Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Curr Pharm Des 13 18 1925 1928 (Pubitemid 47017994)
48. NA Wong F Rae KJ Simpson GD Murray DJ Harrison 2000 Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis Mol Pathol 53 2 88 93 (Pubitemid 30183082)
49. X Wu H Shi H Jiang B Kemp WK Hong GL Delclos MR Spitz 1997 Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer Carcinogenesis 18 5 967 973 (Pubitemid 28132341)
50. RM Wu CW Cheng KH Chen DE Shan JW Kuo YF Ho HD Chern 2002 Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson's disease in Taiwanese J Neural Transm 109 11 1403 1414 (Pubitemid 36560521)
51. M Yang J Tsuang YJ Yvonne Wan 2007 A haplotype analysis of CYP2E1 polymorphisms in relation to alcoholic phenotypes in Mexican Americans Alcohol Clin Exp Res 31 12 1991 2000 (Pubitemid 350150754)